hE-cadherin-pcDNA3 Citations (16)

Originally described in: E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner.
Gottardi CJ, Wong E, Gumbiner BM J Cell Biol. 2001 May 28;153(5):1049-60. PubMed Journal

---

Articles Citing hE-cadherin-pcDNA3

Articles
A Regulatory Network Involving beta-Catenin, e-Cadherin, PI3k/Akt, and Slug Balances Self-Renewal and Differentiation of Human Pluripotent Stem Cells In Response to Wnt Signaling. Huang TS, Li L, Moalim-Nour L, Jia D, Bai J, Yao Z, Bennett SA, Figeys D, Wang L. Stem Cells. 2015 May;33(5):1419-33. doi: 10.1002/stem.1944. PubMed
XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression. Cui T, Srivastava AK, Han C, Yang L, Zhao R, Zou N, Qu M, Duan W, Zhang X, Wang QE. Oncotarget. 2015 Apr 30;6(12):10060-72. PubMed
Activin B promotes endometrial cancer cell migration by down-regulating E-cadherin via SMAD-independent MEK-ERK1/2-SNAIL signaling. Xiong S, Klausen C, Cheng JC, Leung PC. Oncotarget. 2016 Jun 28;7(26):40060-40072. doi: 10.18632/oncotarget.9483. PubMed
miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/beta-Catenin and Notch-1/Akt Signaling Pathways. Song H, Zhang Y, Liu N, Zhao S, Kong Y, Yuan L. Int J Mol Sci. 2016 Oct 27;17(11). pii: E1799. PubMed
PRKAR1A is a functional tumor suppressor inhibiting ERK/Snail/E-cadherin pathway in lung adenocarcinoma. Wang S, Cheng Y, Zheng Y, He Z, Chen W, Zhou W, Duan C, Zhang C. Sci Rep. 2016 Dec 20;6:39630. doi: 10.1038/srep39630. PubMed
miR-151a induces partial EMT by regulating E-cadherin in NSCLC cells. Daugaard I, Sanders KJ, Idica A, Vittayarukskul K, Hamdorf M, Krog JD, Chow R, Jury D, Hansen LL, Hager H, Lamy P, Choi CL, Agalliu D, Zisoulis DG, Pedersen IM. Oncogenesis. 2017 Jul 31;6(7):e366. doi: 10.1038/oncsis.2017.66. PubMed
EpCAM homo-oligomerization is not the basis for its role in cell-cell adhesion. Gaber A, Kim SJ, Kaake RM, Bencina M, Krogan N, Sali A, Pavsic M, Lenarcic B. Sci Rep. 2018 Sep 5;8(1):13269. doi: 10.1038/s41598-018-31482-7. PubMed
Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma. Shields BD, Koss B, Taylor EM, Storey AJ, West KL, Byrum SD, Mackintosh SG, Edmondson R, Mahmoud F, Shalin SC, Tackett AJ. Cancer Res. 2019 Mar 15;79(6):1113-1123. doi: 10.1158/0008-5472.CAN-18-1722. Epub 2019 Jan 23. PubMed
A wave of WNT signaling balanced by secreted inhibitors controls primitive streak formation in micropattern colonies of human embryonic stem cells. Martyn I, Brivanlou AH, Siggia ED. Development. 2019 Mar 25;146(6). pii: dev.172791. doi: 10.1242/dev.172791. PubMed
E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms. Jolly MK, Ware KE, Xu S, Gilja S, Shetler S, Yang Y, Wang X, Austin RG, Runyambo D, Hish AJ, Bartholf DeWitt S, George JT, Kreulen RT, Boss MK, Lazarides AL, Kerr DL, Gerber DG, Sivaraj D, Armstrong AJ, Dewhirst MW, Eward WC, Levine H, Somarelli JA. Mol Cancer Res. 2019 Jun;17(6):1391-1402. doi: 10.1158/1541-7786.MCR-18-0763. Epub 2019 Mar 12. PubMed
Activin A promotes ovarian cancer cell migration by suppressing E-cadherin expression. Yi Y, Cheng JC, Klausen C, Leung PCK. Exp Cell Res. 2019 Jun 20. pii: S0014-4827(19)30311-8. doi: 10.1016/j.yexcr.2019.06.016. PubMed
A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansion. Boone PG, Rochelle LK, Ginzel JD, Lubkov V, Roberts WL, Nicholls PJ, Bock C, Flowers ML, von Furstenberg RJ, Stripp BR, Agarwal P, Borowsky AD, Cardiff RD, Barak LS, Caron MG, Lyerly HK, Snyder JC. Nat Commun. 2019 Dec 2;10(1):5490. doi: 10.1038/s41467-019-13330-y. PubMed
A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Kitchen P, Lee KY, Clark D, Lau N, Lertsuwan J, Sawasdichai A, Satayavivad J, Oltean S, Afford S, Gaston K, Jayaraman PS. Cancer Res. 2020 Feb 15;80(4):757-770. doi: 10.1158/0008-5472.CAN-19-0942. Epub 2019 Dec 16. PubMed
Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma. Tasdemir N, Ding K, Savariau L, Levine KM, Du T, Elangovan A, Bossart EA, Lee AV, Davidson NE, Oesterreich S. Sci Rep. 2020 Jul 13;10(1):11487. doi: 10.1038/s41598-020-68141-9. PubMed
Activation of Hepatic Stellate Cells Requires Dissociation of E-Cadherin-Containing Adherens Junctions with Hepatocytes. Urushima H, Yuasa H, Matsubara T, Kuroda N, Hara Y, Inoue K, Wake K, Sato T, Friedman SL, Ikeda K. Am J Pathol. 2021 Mar;191(3):438-453. doi: 10.1016/j.ajpath.2020.12.007. Epub 2020 Dec 18. PubMed
E-cadherin Interacts With Posttranslationally-Modified AGO2 to Enhance miRISC Activity. Li JN, Sun HL, Wang MY, Chen PS. Front Cell Dev Biol. 2021 Jul 5;9:671244. doi: 10.3389/fcell.2021.671244. eCollection 2021. PubMed

If you have published an article using this material, please email us at to have your article added to this page.